ID: oxytocin
Aliases: Pitocin, synthetic oxytocin, intranasal oxytocin, OXYTOCIN ACETATE
Type: compound
Route/form: IV/IM injection in approved obstetric label; intranasal route is research/off-label context
Status: approved
Evidence level: approved / labelled
Best data tier: approved label + human controlled/review
Support scope: human
Source types: human_rct_negative, label, meta_analysis
Linked sources: 3
Broad outcomes: Brain / mood / sleep, Hormones / fertility / sexual health
Reading note: These are curation notes anchored to linked sources, not a clinical recommendation or protocol.
Targets / mechanism
- oxytocin receptor agonism
- uterotonic effect
- social cognition pathway hypotheses
Optimization domains
- labor
- lactation
- social cognition
- autism
- bonding
- CNS
- endocrine
Research basis
- Approved injectable oxytocin has clear obstetric label context, and intranasal human literature gives a real but mixed social-cognition research base.
Limits, risks, and missing evidence
- Obstetric oxytocin and intranasal social-cognition research are different routes, endpoints, and risk contexts.
- Hyponatremia/water intoxication, uterine hyperstimulation, cardiovascular effects, psychiatric-context variability, and lack of durable social-benefit evidence matter.
Risk flags
- prescription
- uterotonic
- hyponatremia
- blood pressure
- psychiatric context
- route extrapolation
- medical supervision
Linked papers, labels, and reviews
- DailyMed label: PITOCIN oxytocin injection
label / dailymed_oxytocin_label
Oxytocin injection label for obstetric use; includes IV/IM route and water-intoxication/hyponatremia context. - Intranasal oxytocin administration but not peripheral oxytocin regulates behaviors of attachment insecurity: a meta-analysis
meta_analysis / pubmed_intranasal_oxytocin_social_cognition_meta_2021
Human intranasal oxytocin meta-analysis for attachment/social-behavior context. - Intranasal oxytocin in children and adolescents with autism spectrum disorder
human_rct_negative / pubmed_oxytocin_autism_phase2_2021
Large NEJM randomized trial in autism; important counterweight to broad social-cognition claims.